The document provides information on the medication Coreg (carvedilol) including its classification as a beta blocker, dosing, mechanisms of action for treating hypertension, potential side effects and nursing implications such as monitoring blood pressure and pulse during dose adjustments and potential contraindications.
The document provides information on the medication Coreg (carvedilol) including its classification as a beta blocker, dosing, mechanisms of action for treating hypertension, potential side effects and nursing implications such as monitoring blood pressure and pulse during dose adjustments and potential contraindications.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
The document provides information on the medication Coreg (carvedilol) including its classification as a beta blocker, dosing, mechanisms of action for treating hypertension, potential side effects and nursing implications such as monitoring blood pressure and pulse during dose adjustments and potential contraindications.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
NURS 1566 Clinical Form 3: Clinical Medications Worksheets
(You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
carvedilol Coreg Beta blocker 25 mg PO Q am Peak Onset Duration Normal dosage range 1-2 hrs Within 1 hr 12 hrs 6.25 mg twice daily, may be increased q 7-14 days up to 25 mg twice daily Why is your patient getting this medication For IV meds, compatibility with IV drips and/or HTN solutions N/A Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Blocks stimulation of beta1(myocardial) and beta2 Pulmonary edema, cardiogenic shock, bradycardia, heart (pulmonary, vascular, and uterine)-adrenergic block or sick sinus syndrome (unless a pacemaker is in receptor sites. Also has alpha1 blocking activity, place), severe hepatic impairment, asthma or other which may result in orthostatic hypotension. bronchospastic disorders. Use caution in: Diabetes mellitus (may mask signs of hypoglycemia), history of severe allergic reactions (intensity of reactions may be increased), pregnancy, lactation, or children (safety not established; crosses the placenta and may cause fetal/neonatal bradycardia, hypotension, hypoglycemia, or respiratory depression). Common side effects Dizziness, fatigue, weakness, diarrhea, hyperglycemia, BRADYCARDIA, CHF, PULMONARY EDEMA. Interactions with other patient drugs, OTC or Lab value alterations caused by medicine herbal medicines (ask patient specifically) May cause ↑ BUN, serum lipoprotein, potassium, ↑ hypotension may occur with other triglyceride, and uric acid levels. May cause ↑ ANA titers. antihypertensives (Norvasc, Prinivil) , acute May cause ↑ in blood glucose levels. ingestion of alcohol. May alter the effectiveness of Be sure to teach the patient the following about this insulins (Lantus, Novolin R) or oral hypoglycemic medication agents (Glucophage) (dose adjustments may be Instruct patient to take medication as directed, at the same necessary). time each day, even if feeling well. Do not skip or double up on missed doses. Take missed doses as soon as possible up to 4 hr before next dose. Abrupt withdrawal may precipitate life-threatening arrhythmias, hypertension, or myocardial ischemia. Advise patient to make sure enough medication is available for weekends, holidays, and vacations. A written prescription may be kept in wallet in case of emergency. Teach patient and family how to check pulse and blood pressure Instruct them to check pulse daily and blood pressure biweekly. Advise patient to hold dose and contact health care professional if pulse is <50 bpm or blood pressure changes significantly. May cause drowsiness or dizziness. Caution patients to avoid driving or other activities that require alertness until response to the drug is known. Advise patient to change positions slowly to minimize orthostatic hypotension, especially during initiation of therapy or when dose is increased. Caution patient that this medication may increase sensitivity to cold. Instruct patient to consult health care professional before taking any Rx, OTC, or herbal products, especially cold preparations, concurrently with this medication. Patients with diabetes should closely monitor blood glucose, especially if weakness, malaise, irritability, or fatigue occurs. Medication may mask some signs of hypoglycemia, but dizziness and sweating may still occur. Advise patient to notify health care professional if slow pulse, difficulty breathing, wheezing, cold hands and feet, dizziness, confusion, depression, rash, fever, sore throat, unusual bleeding, or bruising occurs. Instruct patient to inform health care professional of medication regimen before treatment or surgery. Advise patient to carry identification describing disease process and medication regimen at all times. Reinforce the need to continue additional therapies for hypertension (weight loss, sodium restriction, stress reduction, regular exercise, moderation of alcohol consumption, and smoking cessation). Medication controls but does not cure hypertension. Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this Check after giving Monitor blood pressure and pulse med? Decrease in blood pressure frequently during dose adjustment period Monitor patients receiving beta without appearance of and periodically during therapy Assess for blockers for signs of overdose detrimental side effects. orthostatic hypotension when assisting (bradycardia, severe dizziness or patient up from supine position. Monitor fainting, severe drowsiness, dyspnea, intake and output ratios and daily weight. bluish fingernails or palms, seizures). Assess patient routinely for evidence of Notify physician or other health care fluid overload (peripheral edema, professional immediately if these dyspnea, rales/crackles, fatigue, weight signs occur. Take apical pulse before gain, jugular venous distention). Patients administering. If <50 bpm or if may experience worsening of symptoms arrhythmia occurs, withhold during initiation of therapy for CHF. medication and notify physician or Check frequency of refills to determine other health care professional. adherence.